SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-17-005794
Filing Date
2017-03-31
Accepted
2017-03-31 16:49:48
Documents
88
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tlcc20161231_10k.htm 10-K 1501909
2 EXHIBIT 14.1 ex14-1.htm EX-14.1 40279
3 EXHIBIT 21.1 ex21-1.htm EX-21.1 8554
4 EXHIBIT 23.1 ex23-1.htm EX-23.1 2824
5 EXHIBIT 31.1 ex31-1.htm EX-31.1 16298
6 EXHIBIT 31.2 ex31-2.htm EX-31.2 16181
7 EXHIBIT 32.1 ex32-1.htm EX-32.1 7196
8 EXHIBIT 32.2 ex32-2.htm EX-32.2 7032
  Complete submission text file 0001437749-17-005794.txt   8256914

Data Files

Seq Description Document Type Size
9 EXHIBIT 101.INS tlcc-20161231.xml EX-101.INS 1513491
10 EXHIBIT 101.SCH tlcc-20161231.xsd EX-101.SCH 89827
11 EXHIBIT 101.CAL tlcc-20161231_cal.xml EX-101.CAL 74893
12 EXHIBIT 101.DEF tlcc-20161231_def.xml EX-101.DEF 645818
13 EXHIBIT 101.LAB tlcc-20161231_lab.xml EX-101.LAB 504612
14 EXHIBIT 101.PRE tlcc-20161231_pre.xml EX-101.PRE 672459
Mailing Address 632 BROADWAY SUITE 201 NEW YORK NY 10012
Business Address 632 BROADWAY SUITE 201 NEW YORK NY 10012 (212) 651-8500
TWINLAB CONSOLIDATED HOLDINGS, INC. (Filer) CIK: 0001590695 (see all company filings)

IRS No.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55181 | Film No.: 17731025
SIC: 2833 Medicinal Chemicals & Botanical Products